Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07565246 · ClinicalTrials.gov registry record
A Study to Understand the Analgesic Properties of Topically Applied Menthol When Used in a Marathon.
A clinical trial, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- Completed
- Registry status
- 367
- Enrollment target
NCT07565246: Completed study, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
NCT07565246 is a clinical trial that has completed, run by Reckitt Benckiser Healthcare (UK) Limited. The registered enrollment target is 367 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07565246 has completed, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- COMPLETED
- Registry status
- 367 participants
- Enrollment target
Study Summary
The purpose of the research study is to gather the opinions and/or perceptions relating to the use of topically applied menthol and experience of pain during and after a marathon in adult runners (18+ years) participating in the 2025 Chicago Marathon. The main questions it aims to answer are: * Does topically applied menthol reduce pain levels in marathon runners during recovery? * How quickly does pain relief occur after topically applied menthol application? * What are the sensory attributes (e.g., cooling sensation) associated with topically applied menthol use during and after the race? * How do demographic factors (e.g., age, sex, menstrual cycle stage, sleep quality) influence pain experience and topically applied menthol effectiveness? Researchers will compare pre- and post-application pain scores in the Recovery Application Zone to see if Biofreeze provides measurable pain relief and sensory benefits. Participants will: * Provide documented informed consent prior to participation. * Self-select to use Biofreeze products during or after the race. * Complete one or both of the following: 1. Recovery Application Zone Questionnaire (includes pain score before and after Biofreeze application, sensory assessments, demographics). 2. End of Race Questionnaire (includes retrospective recall of pain relief, product use, sensory experience, and demographic data).
Primary Outcome
Pain relief was assessed by change in Numeric Rating Scale (NRS) 0-10 pre and post topical menthol application.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2025-10-12 |
| Est. Completion | 2025-10-12 |
What the finished NCT07565246 record still lists
NCT07565246 is an observational study that tracks outcomes without assigning an intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT07565246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07565246 about?
NCT07565246 is a clinical study titled "A Study to Understand the Analgesic Properties of Topically Applied Menthol When Used in a Marathon.". The purpose of the research study is to gather the opinions and/or perceptions relating to the use of topically applied menthol and experience of pain during and after a marathon in adult runners (18+ years) participating in the 2025 Chicago Marathon. The main questions it aims to answer are: * Doe...
What is the current status of trial NCT07565246?
This trial is currently completed. The enrollment target is 367 participants. The study started on 2025-10-12. Estimated completion is 2025-10-12.
What interventions are being tested in trial NCT07565246?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT07565246?
This trial is sponsored by Reckitt Benckiser Healthcare (UK) Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI